Name | Carlumab |
---|
Description | Carlumab (CNTO 888) is a humanised anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer[1]. |
---|---|
Related Catalog | |
Target |
CCL2[1]. |
References |
No Any Chemical & Physical Properties |